Solving Kids’ Cancer UK’s Chair of Trustees awarded MBE
Chair of Trustees, Nick Bird, has been awarded an MBE in the 2025 New Year Honours list for his exceptional services to research and advocacy for children affected by neuroblastoma.
Our Response to the NHS 10-Year Health Plan Consultation
As the government prepares it's 10 Year Health Plan, Solving Kids' Cancer has taken the opportunity to highlight the needs of children with cancer that must be recognised.
Meet the Thuraisingham Family: How Solving Kids’ Cancer UK’s Supporters Make a Difference
The neuroblastoma community plays a crucial role in raising awareness and generating much-needed funds for Solving Kids' Cancer UK.
Solving Kids' Cancer UK at the 2024 Party Conferences
This year we made our debut visit to the Labour and Conservative Party Conferences. Public Affairs & Advocacy Lead, Emily, reflects on the experience.
AMXT1501/DFMO (polyamine inhibition) therapy
AMXT1501/DFMO (polyamine inhibition) therapy
New decision-making tool for treatment of relapsed and refractory neuroblastoma launched
A brand new support tool developed by Advanced Nurse Practitioner Helen Pearson is now available to parents facing difficult decisions in their child's treatment and care.
Funding award extends clinical trial for children with relapsed or refractory neuroblastoma
We're pleased to announce the extension of funding for the MiNivAn trial, investigating new combination therapies for children with relapsed or refractory high-risk neuroblastoma.
Solving Kids’ Cancer UK announces three-year charity partnership with Julius Baer International Ltd
Solving Kids’ Cancer UK is proud to announce a new three-year charity partnership with Julius Baer International Ltd, the UK entity of one of the world’s leading wealth management firms.
New funding for Senior Trial Coordinator post at Cancer Research Clinical Trials Unit
Solving Kids’ Cancer UK are pleased to announce renewed funding for the Cancer Research Clinical Trials Unit (CRCTU) at the University of Birmingham.
